Schulman, Ferro prepare for next stage in bid, proxy fight

22:34 PM | April 15, 2013 | —Vincent Valk and Rebecca Coons

Ferro sold its pharmaceuticals business, increased its earnings guidance, and issued a letter to shareholders, while A. Schulman fell short of estimates and amended CEO Joseph Gingo’s contract...